Number of items: 6.
Article
GLP-1 and dual GIP/GLP-1 receptor agonists’ psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill–informed, systematic, evaluation. (2026)
Fabrizio Schifano,
Maria Antonietta De Luca,
Stefania Bonaccorso,
Davide Arillotta,
Giuseppe Floresta,
Giovanni Martinotti,
Gabriele Duccio Papanti,
John Martin Corkery,
Stefania Chiappini
and
Amira Guirguis
picture_as_pdf
Tolazoline, an alpha-adrenergic antagonist, may also block xylazine at off-target sites as inferred from molecular docking. (2026)
Giuseppe Floresta,
Vincenzo Patamia,
Alberto Granzotto,
Davide Arillotta,
Gabriele Duccio Papanti,
Amira Guirguis,
John Martin Corkery,
Giovanni Martinotti,
Stefano L. Sensi
and
Fabrizio Schifano
picture_as_pdf
Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and ‘Smart Drug’ Use and Misuse. (2025)
Fabrizio Schifano,
Stefania Bonaccorso,
Davide Arillotta,
John Martin Corkery,
Giuseppe Floresta,
Gabriele Duccio Papanti
and
Amira Guirguis
Use of Medicinal Cannabis and Synthetic Cannabinoids in Posttraumatic Stress Disorder (PTSD): a systematic review. (2019)
Laura Orsolini,
Stefania Chiappini,
Umberto Volpe,
Domenico De Berardis,
Roberto Latini,
Gabriele Duccio Papanti
and
John Corkery
Post-traumatic stress and substance misuse; neurobiological and clinical pharmacological correlates. (2018)
Fabrizio Schifano,
Gabriele Duccio Papanti,
John Corkery
and
Laura Orsolini
description
Mind Navigators of Chemicals' Experimenters? A Web-Based Description of E-Psychonauts. (2015)
Laura Orsolini,
Gabriele Duccio Papanti,
Giulia Francesconi
and
Fabrizio Schifano
picture_as_pdf
This list was generated on Sun Oct 4 02:01:12 2026 BST.